333795-06-5

Basic information

• Product Name: Piperidine, 4-[[4-(methylsulfonyl)phenyl]methyl]-
• CAS NO: 333795-06-5
• Molecular Formula: C13H19NO2S
• Molecular Weight: 253.365
• Mol File: 333795-06-5.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Piperidine, 4-[[4-(methylsulfonyl)phenyl]methyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Piperidine, 4-[[4-(methylsulfonyl)phenyl]methyl]-(333795-06-5)
• EPA Substance Registry System: Piperidine, 4-[[4-(methylsulfonyl)phenyl]methyl]-(333795-06-5)

Safety Data

• Hazardous Substances Data: 333795-06-5(Hazardous Substances Data)

Upstream product

• 101997-42-6 1-(4-benzylpiperidin-1-yl)ethan-1-one 
• 31252-42-3 4-benzylpyperidine 
• 333795-03-2 4-[(1-acetyl-4-piperidinyl)methyl]benzenesulfonyl chloride 
• 333795-04-3 1-acetyl-4-[4-(methylsulfonyl)benzyl]piperidine 

Downstream Products

• 333988-32-2 4-Propyl-N-(3-{4-[4-(methylsulfonyl)benzyl]-1-piperidinyl}propyl)aniline 
• 333988-33-3 4-Butyl-N-(3-{4-[4-(methylsulfonyl)benzyl]-1-piperidinyl}propyl)aniline 
• 333988-29-7 4-Fluoro-N-(3-{4-[4-(methylsulfonyl)benzyl]-1-piperidinyl}propyl)aniline 
• 333988-31-1 4-Ethyl-N-(3-{4-[4-(methylsulfonyl)benzyl]-1-piperidinyl}propyl)aniline 
• 333988-30-0 3-Ethyl-N-(3-{4-[4-(methylsulfonyl)benzyl]-1-piperidinyl}propyl)aniline 
• 333988-34-4 4-tert-Butyl-N-(3-{4-[4-(methylsulfonyl)benzyl]-1-piperidinyl}propyl)aniline 

Relevant articles and documents

USE OF COMPOUNDS HAVING CCR ANTAGONISM

It is intended to provide preventives/remedies for graft-versus-host disease and/or rejection in organ or bone marrow transplantation, rheumatoid arthritis, autoimmune diseases, allergic diseases, ischemic cerebral cell injury, myocardial infarction, chro

CCR5 antagonists as anti-HIV-1 agents. Part 2: Synthesis and biological evaluation of N-[3-(4-benzylpiperidin-1-yl)propyl]-N,N′- diphenylureas

We have previously reported the novel lead compound 1a as a CCR5 antagonist for treatment of HIV-1 infection. SAR studies on incorporating various acyl groups as a replacement for the 5-oxopyrrolidine-3-carbonyl group of the lead structure resulted in the

UREA COMPOUNDS, PROCESS FOR PRODUCING THE SAME AND USE THEREOF

A compound of the formula: [whereinR1 is a hydrocarbon group which may be substituted;R2 is a cyclic hydrocarbon group which may be substituted or a heterocyclic group which may be substituted;R3 is halogen atoms, a carbam